Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEUCRAVACITINIB vs DEXCHLORPHENIRAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEUCRAVACITINIB vs DEXCHLORPHENIRAMINE: Safety Overview

Metric DEUCRAVACITINIB DEXCHLORPHENIRAMINE
Total FAERS Reports 2,386 1,596
Deaths Reported 36 128
Death Rate 1.5% 8.0%
Hospitalizations 121 813
Average Patient Age 56.8 yrs 58.5 yrs
% Female Patients 63.8% 59.8%
FDA Approval Date Sep 9, 2022 Approved Prior to Jan 1, 1982
Manufacturer E.R. Squibb & Sons, L.L.C. CARWIN PHARMACEUTICAL ASSOCIATES, LLC
Route ORAL ORAL
Marketing Status Prescription Discontinued